Advertisement
Elekta logo

Global medical device company Elekta won Japanese regulatory approval for its Agility radiation therapy system, which boasts twice as many beam-shaping tungsten leaves as typical systems.

Global medical device company Elekta (STO:EKTA B) won Japanese regulatory approval for its Agility radiation therapy system, which promises "faster, more accurate cancer treatments on the horizon."

The Agility system utilizes Elekta's multi-leaf collimator, a "device made up of numerous, individual tungsten 'leaves'," which shapes radiation therapy beams to deliver treatment from different angles around the patient, according to a press release.

Agility features 160 tungsten leaves, twice as many as typical MLCs, according to the company. The leaves provide more precise radiation beam targeting that helps protects healthy tissue from exposure.

Advertisement
Advertisement